NKCx Histopathological outcome* within 12 months after cervix cytology in 2018 |
088 (081) Huddinge |
Benign | CIN1 | CIN2 | CIN3 | AIS | Cancer | Other | PAD missing | Total | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cytology | Count | Pct | Count | Pct | Count | Pct | Count | Pct | Antal | Andel | Count | Pct | Count | Pct | Count | Pct | Count | Pct |
Benign sample | 464 | 1.5% | 255 | 0.8% | 8 | 0.0% | 116 | 0.4% | 4 | 0.0% | 4 | 0.0% | 62 | 0.2% | 29568 | 97.0% | 30481 | 100.0% |
ASCUS | 364 | 24.0% | 373 | 24.6% | 4 | 0.3% | 263 | 17.3% | 5 | 0.3% | 1 | 0.1% | 74 | 4.9% | 434 | 28.6% | 1518 | 100.0% |
CIN1 | 411 | 24.3% | 567 | 33.5% | 20 | 1.2% | 337 | 19.9% | 3 | 0.2% | . | . | 56 | 3.3% | 300 | 17.7% | 1694 | 100.0% |
Atypical glandular cells/AGC | 12 | 10.9% | 29 | 26.4% | . | . | 47 | 42.7% | 7 | 6.4% | 9 | 8.2% | 2 | 1.8% | 4 | 3.6% | 110 | 100.0% |
Unclear atypia | 5 | 41.7% | 3 | 25.0% | . | . | 3 | 25.0% | . | . | . | . | . | . | 1 | 8.3% | 12 | 100.0% |
ASC-H | 27 | 11.3% | 36 | 15.1% | 5 | 2.1% | 149 | 62.3% | 2 | 0.8% | 5 | 2.1% | 11 | 4.6% | 4 | 1.7% | 239 | 100.0% |
CIN3 | 83 | 7.8% | 90 | 8.5% | 8 | 0.8% | 833 | 78.3% | 12 | 1.1% | 12 | 1.1% | 12 | 1.1% | 14 | 1.3% | 1064 | 100.0% |
Adenocarcinoma | 1 | 2.2% | 5 | 10.9% | . | . | 12 | 26.1% | 13 | 28.3% | 15 | 32.6% | . | . | . | . | 46 | 100.0% |
Squamous cell cancer | . | . | 1 | 5.0% | . | . | 16 | 80.0% | . | . | 2 | 10.0% | . | . | 1 | 5.0% | 20 | 100.0% |
Total | 1367 | 3.9% | 1359 | 3.9% | 45 | 0.1% | 1776 | 5.0% | 46 | 0.1% | 48 | 0.1% | 217 | 0.6% | 30326 | 86.2% | 35184 | 100.0% |
NOTE: Histopathological outcome from T83x taken into account. |
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad. |
* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead. |
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'. |
Process Registry's Class 1 (benign), 2d (CIN1) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories. |
Snomed codes in the category Cancer: |
---|
M80001, M80413, M80703, M81401, M81403, M83803 |